The Division of Molecular Medicine and Gene Therapy is located at the Biomedical Center (BMC), Lund University, Sweden. Established as a joint venture between the Medical Faculty at Lund University and the Hematology Clinic at Lund University Hospital, our mission is to translate basic science to clinical applications.
Our research focuses on hematopoiesis, the continuous and dynamic process of blood cell formation. The laboratory consists of eight closely collaborating research groups that all share a common interest in investigating the properties of blood stem cells to eventually understand and treat hematological disorders.
Five of our researchers belong to the Hemato-Linné Excellence Linnaeus Research Environment funded by The Swedish Research Council and Lund University. Several of the groups are engaged in StemTherapy, a Strategic Research Area for Stem Cells and Regenerative Medicine that is also supported by The Swedish Research Council.
The Swedish Cancer Society has taken decisions on this year's open call for research projects. Six grants were awarded to researchers at the Divisions of Molecular Hematology and Molecular Medicine and Gene Therapy.
We congratulate Cristian Bellodi, Filipe Pereira, Mattias Magnusson, Mikael Sigvardsson, Niels-Bjarne Woods, and Stefan Scheding on their success in receiving funding. Altogether, they were awarded grants worth 15.5 million SEK.
Please welcome our two new colleagues Rita Alves and Gabriela Ferreira to the Division of Molecular Medicine and Gene Therapy. Rita and Gabriela are both joining us from the University of Coimbra, Portugal.
Welcome to our Division, to Lund, and to Sweden, Rita and Gabriela!
The Swedish Research Council has taken decisions on applications within Medicine and Health.
We congratulate Johan Flygare on being awarded funding from the Swedish Research Council for a project that aims to advance our understanding of the molecular mechanisms underlying red blood cell production and potential new treatment options for anemia.
On Wednesday, October 18, 2017, Svetlana Soboleva will present her half-time seminar entitled "Exploring novel mechanisms of erythropoiesis to develop therapies for anemia".
Time and venue
October 18, 2017 at 14:00
Seminar room BMC I1345
Kenichi Miharada, Division of Molecular Medicine and Gene Therapy
John W Semple, Division of Hematology and Transfusion Medicine, Lund University
Jill Storry, Division of Hematology and Transfusion Medicine, Lund University